Oncocyte Corp Files 8-K on Financials
Ticker: IMDX · Form: 8-K · Filed: May 12, 2025 · CIK: 1642380
Sentiment: neutral
Topics: financial-condition, sec-filing
TL;DR
Oncocyte Corp filed an 8-K on 5/12/25 for financial updates.
AI Summary
On May 12, 2025, Oncocyte Corporation filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.
Why It Matters
This 8-K filing indicates Oncocyte Corporation is providing updates on its financial performance and condition to the SEC.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate operational or financial distress.
Key Players & Entities
- Oncocyte Corporation (company) — Registrant
- May 12, 2025 (date) — Date of Report
- California (location) — State of incorporation
- 1-37648 (company_id) — Commission File Number
- 27-1041563 (company_id) — IRS Employer Identification No.
- 15 Cushing Irvine, California 92618 (address) — Address of principal executive offices
- 949-409-7600 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported by Oncocyte Corporation in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the excerpt does not contain specific financial figures.
When was this 8-K report filed by Oncocyte Corporation?
The report was filed on May 12, 2025.
What is Oncocyte Corporation's principal executive office address?
The address is 15 Cushing Irvine, California 92618.
What is the Commission File Number for Oncocyte Corporation?
The Commission File Number is 1-37648.
What is the IRS Employer Identification Number for Oncocyte Corporation?
The IRS Employer Identification Number is 27-1041563.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding Oncocyte Corp (IMDX).